Quantitation of MYC gene expression in sporadic breast tumors with a real-time reverse transcription-PCR assay

Cancer Research

Volumn 59, Issue 12, 1999, Pages 2759-2765

  Bièche, Ivan ^a,b   Laurendeau, Ingrid ^a   Tozlu, Sengül ^b   Olivi, Martine ^a   Vidaud, Dominique ^a   Lidereau, Rosette ^b   Vidaud, Michel ^a  

^a FACULTÉ DES SCIENCES PHARMACEUTIQUES ET BIOLOGIQUES   (France)

^b CENTRE RENÉ HUGUENIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST TUMOR; CELL PROLIFERATION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; ONCOGENE MYC; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; GENE DOSAGE; GENE EXPRESSION; GENES, MYC; HUMANS; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0141765653     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Henriksson, M., and Luscher, B. Proteins of the Myc network: essential regulators of cell growth and differentiation. Adv. Cancer Res., 68: 109-182, 1996.
2. Bouchard, C., Staller, P., and Eilers, M. Control of cell proliferation by Myc. Trends Cell Biol., 8: 202-206, 1998.
3. He, T-C., Sparks, A. B., Rago, C., Hermeking, H., Zawel, L., Da Costa, L. T., Morin, P. J., Vogelstein, B., and Kinder, K. W. Identification of c-myc as a target of the APC pathway. Science (Washington DC), 281: 1509-1512, 1998.
4. Watson, P. H., Pon, R. T., and Shiu, R. P. C. Inhibition of c-myc expression by phosphorothioate antisense oligonucleotide identifies a critical role for c-myc in the growth of human breast cancer Cancer Res., 51: 3996-4000, 1991.
5. Pennisi, E. How a growth control path takes a wrong turn to cancer. Science (Washington DC), 281: 1438-1441, 1998.
6. Morse, B., Rotherg, P. G., South, V. J., Spandorfer, J. M., and Astrin, S. M. Insertional mutagenesis of the myc locus by a LINE-1 sequence in a human breast carcinoma. Nature (Lond.), 333: 87-90, 1988.
7. Escot, C., Theillet, C., Lidereau, R., Spyratos, F., Champeme, M-H., Gest, J., and Callahan, R. Genetic alteration of the c-myc protooncogene (MYC) in human primary breast carcinomas. Proc. Natl. Acad. Sci. USA, 83: 4834-4838, 1986.
8. Mass, S. J., and Dickson, R. B. Defining a role for c-myc in breast tumorigenesis. Breast Cancer Res. Treat., 44: 1-22, 1997.
9. Borg, A., Baldetorp, B., Berno, M., Olsson, H., and Sigurdsson, H. c-myc is an independent prognostic factor in postmenopausal breast cancer. Int. J. Cancer, 51: 687-691, 1992.
10. Courjal, F., Cuny, M., Simony-Lafontaine, J., Louasson, G., Speiser, P., Zeillinger, R., Rodriguez, C., and Theillet, C. Mapping of DNA amplification at 15 chromosomal localization in 1875 breast tumors: definition of phenotypic groups. Cancer Res., 57: 4360-4367, 1997.
11. Bièche, I., Olivi, M., Champeme, M-H., Vidaud, D., Lidereau, R., and Vidaud, M. Novel approach to quantitative polymerase chain reaction using real-time detection: application to the detection of gene amplification in breast cancer. Int. J. Cancer, 78: 661-666, 1998.
12. Visscher, D. W., Wallis, T., Awussah, S., Mohamed, A., and Crissman, J. D. Evaluation of MYC and chromosome 8 copy number in breast carcinoma by interphase cytogenetics. Genes Chromosomes Cancer, 18: 1-7, 1997.
13. Walker, R. A., Senior, P. V., Jones, J. L., Critchley, D. R., and Varley, J. M. An immunohistochemical and in situ hybridization study of c-myc and c-erbB-2 expression in primary human breast carcinomas. J. Pathol., 158: 97-105, 1989.
14. Gibson, U. E. M., Heid, C. A., and Wiiliams, P. M. A novel method for real time quantitative RT-PCR. Genome Res., 6: 995-1001, 1996.
15. Dimhofer, S., Berger, C., Untergasser, G., Geley, S., and Berger, R. Human β-actin retropseudogenes interfere with RT-PCR. Trends Genet., 11: 380-381, 1995.
16. Sellner, L. N., and Turbett, G. R. The presence of a pseudogene may affect the use of HPRT as an endogenous mRNA control in RT-PCR. Mol. Cell Probes, 10: 481-483, 1996.
17. Mullen, C. A. Review: analogies between trophoblastic and malignant cells. Am. J. Reprod. Immunol., 39: 41-49, 1998.
18. Kaplan, E. L., and Meier, P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc., 53: 457-481, 1958.
19. Guerin, M., Barrois, M., Terrier, M. J., Spielmann, M., and Riou, G. Overexpression of either c-myc or c-erbB-2/neu proto-oncogenes in human breast carcinomas: correlation with poor prognosis. Oncogene Res., 3: 21-31, 1988.
20. Mariani-Costantini, R., Escot, C., Theillet, C., Gentile, A., Merlo, G., Lidereau, R., and Callahan, R. In situ c-myc expression and genomic status of the c-myc locus in infiltrating ductal carcinomas of the breast. Cancer Res., 48: 199-205, 1988.
21. Wang, Q., Zhang, H., Kajino, K., and Greene, M. I. BRCA1 binds c-myc and inhibits its transcriptional and transforming activity in cells. Oncogene, 17: 1939-1948, 1998.
22. Ray, R. B., Steele, R., Seftor, E., and Hendrix, M. Human breast carcinoma cells transfected with the gene encoding a c-myc promoter-binding protein (MBP-1) inhibits tumors in nude mice. Cancer Res., 55: 3747-3751, 1995.
23. Pavelic, Z. P., Pavelic, L., Lower, E. E., Gapany, M., Gapany, S., and Barker, E. A. c-myc, c-erbB-2, and Ki-67 expression in normal breast tissue and in invasive and noninvasive breast carcinoma. Cancer Res., 52: 2597-2602, 1992.
24. Kang, Y., Cortina, R., and Perry, R. R. Role of c-myc in tamoxifen-induced apoptosis in estrogen-independent breast cancer cells. J. Natl. Cancer Inst., 88: 279-284, 1996.
25. Smith, D. R., and Goh, H. S. Overexpression of the c-myc proto-oncogene in colorectal carcinoma is associated with a reduced mortality that is abrogated by point mutation of the p53 tumor suppressor gene. Clin. Cancer Res., 2: 1049-1053, 1996.
26. Le Roy, X., Escot, C., Brouillet, J-P., Theillet, C., Maudelonde, T., Simony-Lafontaine, J., Pujol, H., and Rochefort, H. Decrease of c-erbB-2 and c-myc RNA levels in tamoxifen-treated breast cancer. Oncogene, 6: 431-437, 1991.
27. Thomas, T. J., Faaland, C. A., Gallo, M. A., and Thomas, T. Suppression of c-myc oncogene expression by a polyamine-complexed triplex forming oligonucleotide in MCF-7 breast cancer cells. Nucleic Acids Res., 23: 3594-3599, 1995.
28. ink4a and of hypophosphorylated retinoblastoma family proteins. EMBO J., 16: 5322-5333, 1997.
29. WAF1/CIP1/SDI1. Oncogene, 11: 1409-1415, 1995.
30. Zindy, F., Eischen, C. M., Randle, D. H., Kamijo, T., Cleveland, J. L., Sherr, C. J., and Roussel, M. F. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev., 12: 2424-2433, 1998.
31. Sikora, K., Chan, S., Evan, G., Gabra, H., Markham, N., Stewart, J., and Watson, J. c-myc oncogene expression in colorectal cancer. Cancer (Phila.), 59: 1289-1295, 1987.